Home » Topics » Regulatory

Regulatory
RSS

InterMune files BLA for Actimmune for treatment of osteopetrosis

Aug. 25, 1999

Bio-Technology General granted additional patent allowance for oxandrolone

Aug. 24, 1999

QLT begins phase II trial for psoriasis treatment

Aug. 24, 1999

Chiron initiates phase III study of Proleukin for HIV

Aug. 23, 1999

FDA approves Organon's short-acting neuromuscular blocker Raplon

Aug. 19, 1999

FDA approves Cleocin vaginal ovules for treatment of bacterial vaginosis

Aug. 19, 1999

Etanercept trial results in psoriatic arthritis announced

Aug. 18, 1999

Preclinical study results indicate efficacy of thiazolidinediones in IBD

Aug. 16, 1999

Bayer will launch new quinolone on September 1

Aug. 13, 1999

Emdogain approved by FDA for minimally invasive dental surgery

Aug. 13, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 10, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 10, 2025.
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...
Brenig Therapeutics discovers new LRRK2 inhibitors
BioWorld Science
Brenig Therapeutics Inc. has described leucine-rich repeat kinase 2 (LRRK2; dardarin) and (LRRK2; dardarin) (G2019S mutant) inhibitors reported to be useful for...